Alpeen Injection, specifically the 4000 IU formulation, is primarily used to treat anemia in patients suffering from End Stage Kidney Disease (ESKD). This treatment is applicable whether the patient is undergoing hemodialysis or not.
Key Use of Alpeen Injection:
- Anemia Management in ESKD Patients: The main function of Alpeen Injection is to increase red blood cell production, thereby alleviating anemia, which is a common complication of ESKD.
- This helps reduce symptoms associated with anemia, such as fatigue, weakness, and shortness of breath.
How Alpeen Injection Works:
Alpeen Injection contains a synthetic version of erythropoietin, a hormone naturally produced by the kidneys. In patients with ESKD, the kidneys cannot produce enough erythropoietin, leading to anemia. Alpeen Injection supplements this hormone, stimulating the bone marrow to produce more red blood cells.
Specific Uses:
| Condition | Treatment Goal |
|---|---|
| ESKD with Hemodialysis | Correct anemia caused by reduced erythropoietin production |
| ESKD without Hemodialysis | Correct anemia caused by reduced erythropoietin production |
Summary:
In essence, Alpeen Injection provides erythropoietin to patients with ESKD whose own kidneys cannot produce enough of this vital hormone to maintain adequate red blood cell counts, effectively treating the resulting anemia.
